Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Nov 09, 2023 $14.28 $14.71 $13.23 $13.59 590 663
Nov 08, 2023 $14.83 $14.89 $13.92 $14.08 1 156 176
Nov 07, 2023 $14.91 $15.04 $14.62 $14.75 715 531
Nov 06, 2023 $15.17 $15.62 $14.78 $14.90 743 201
Nov 03, 2023 $14.50 $15.87 $14.45 $15.19 1 276 077
Nov 02, 2023 $13.00 $14.29 $12.87 $14.08 1 284 104
Nov 01, 2023 $12.51 $12.62 $11.81 $12.60 1 173 426
Oct 31, 2023 $12.92 $13.01 $12.15 $12.50 1 516 046
Oct 30, 2023 $12.75 $13.98 $12.61 $13.02 1 457 048
Oct 27, 2023 $12.71 $12.83 $12.24 $12.38 538 102
Oct 26, 2023 $11.76 $12.79 $11.17 $12.67 826 710
Oct 25, 2023 $11.01 $11.84 $10.93 $11.67 543 537
Oct 24, 2023 $11.13 $11.50 $11.03 $11.20 1 473 354
Oct 23, 2023 $11.27 $11.60 $11.05 $11.12 611 354
Oct 20, 2023 $11.80 $11.94 $11.46 $11.58 475 564
Oct 19, 2023 $11.88 $11.95 $11.44 $11.76 1 351 574
Oct 18, 2023 $12.00 $12.08 $11.77 $11.83 559 585
Oct 17, 2023 $11.89 $12.47 $11.73 $12.11 577 454
Oct 16, 2023 $12.36 $12.36 $11.81 $11.88 524 888
Oct 13, 2023 $12.19 $12.41 $11.82 $12.34 1 079 204
Oct 12, 2023 $13.13 $13.13 $12.14 $12.15 1 252 086
Oct 11, 2023 $14.10 $14.10 $13.01 $13.29 607 196
Oct 10, 2023 $13.91 $14.33 $13.40 $14.10 1 298 790
Oct 09, 2023 $13.90 $14.00 $13.44 $13.84 495 778
Oct 06, 2023 $14.17 $14.37 $13.82 $14.08 574 614
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT